VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward

Abstract

Mechanistic target of rapamycin (mTOR) regulates long-term synaptic plasticity, learning, and memory by controlling dendritic protein synthesis. The mTOR inhibitor rapamycin has been shown to attenuate the behavioral effects of drugs of abuse, including cocaine. Using viral vectors to selectively delete mTOR in the ventral tegmental area (VTA) in adult male mTOR^loxP/loxP mice, we investigated the role of mTOR in regulating neuronal morphology, basal synaptic transmission, dopamine dynamics, and cocaine-induced synaptic plasticity and rewarding effects. We find that targeted deletion of mTOR in the VTA had no significant effects on soma size and dendritic morphology of VTA neurons but significantly decreased dopamine release and reuptake in the nucleus accumbens (NAc) shell, a major target region. Western blot analysis revealed that mTOR deletion led to decreases in phosphorylated tyrosine hydroxylase (pTH-Ser40) levels in the VTA and dopamine transporter expression in the NAc. mTOR deletion had no significant effects on basal excitatory transmission in VTA dopamine neurons but caused an increase in GABAergic inhibition because of an increase in VTA GABAergic neuron firing. Furthermore, mTOR deletion attenuated conditioned place preference to cocaine and cocaine-induced potentiation of excitation and reduction of GABAergic inhibition in VTA dopamine neurons. Taken together, these results suggest that loss of mTOR in the VTA shifts the balance of excitatory and inhibitory synaptic transmission and decreases dopamine release and reuptake in the NAc. In addition, VTA mTOR signaling regulates cocaine-cue associative learning and cocaine-induced synaptic plasticity in VTA dopamine neurons.

Introduction

The serine/threonine-protein kinase mechanistic (formerly mammalian) target of rapamycin (mTOR) is a powerful regulator of protein synthesis and controls neurodevelopment, cell growth, survival, and differentiation (Laplante and Sabatini, 2012). mTOR interacts with many proteins to form two distinct multiprotein complexes—mTORC1 and mTORC2—and controls protein synthesis by sensing nutrient and energy levels (Zoncu et al, 2011). The formation and consolidation of memories require de novo protein synthesis (Costa-Mattioli and Monteggia, 2013). mTOR controls synthesis of synaptic proteins at dendrites and regulates important brain functions such as long-term synaptic plasticity and learning and memory (Hoeffer and Klann, 2010; Costa-Mattioli and Monteggia, 2013; Huang et al, 2013). Dysfunction of mTOR signaling pathways has been implicated in diseases such as autism and epilepsy (Huber et al, 2015).

Addictive drugs usurp the neural mechanisms normally subserving reward-related learning, and exposure to drugs of abuse activates similar intracellular signaling pathways as learning and memory and is associated with similar alterations in synaptic plasticity (Nestler, 2013; Dong and Nestler, 2014). Protein synthesis is required for several drug-induced adaptations, such as long-term potentiation (LTP) (Argilli et al, 2008; Yuan et al, 2013) and long-term depression (LTD) (Mameli et al, 2007; Yu et al, 2013) in the ventral tegmental area (VTA). Psychostimulants (cocaine, amphetamine), cannabinoids, opiates (morphine), and alcohol activate mTOR signaling in the mesolimbic reward circuit, and systemic injection or microinjection of the mTORC1 inhibitor rapamycin into the nucleus accumbens (NAc) attenuates drug- or alcohol-associated behaviors, such as relapse and reinforcement learning (Dayas et al, 2012; Barak et al, 2013; Neasta et al, 2014; Beckley et al, 2016). Morphine increases mTORC1 signaling but decreases mTORC2 signaling in the VTA, and Akt–mTORC2 signaling regulates morphine-induced neuroadaptations and reward tolerance (Mazei-Robison et al, 2011) and the psychomotor effects of amphetamine (Dadalko et al, 2015). Systemic or intra-NAc injections of rapamycin attenuate cocaine-induced reward and reinforcement behaviors. Specifically, intra-NAc injections of rapamycin attenuate cue-induced reinforcement and reinstatement of cocaine seeking (Wang et al, 2010; James et al, 2014, 2016). Systemic injection of rapamycin attenuates the expression of cocaine-induced locomotor sensitization and conditioned place preference (CPP) in mice (Bailey et al, 2012) or the acquisition of cocaine-induced locomotor sensitization in rats (Wu et al, 2011). However, the mechanisms by which mTOR inhibition attenuates the behavioral effects of cocaine remain poorly understood.

Here, we used a Cre/LoxP system to produce VTA-specific deletion of mTOR and investigated its impact on soma size and dendritic morphology, basal synaptic transmission, dopamine dynamics, and cocaine-induced neuroadaptations and reward. AAV2-Cre-GFP was microinjected into the VTA of adult mTOR^loxP/loxP mice to induce targeted deletion of mTOR. Although mTOR exists in two distinct protein complexes, mTORC1 and mTORC2, and these can be differentially regulated by drugs of abuse (Mazei-Robison et al, 2011; Sutton and Caron, 2015), mTORC1 and mTORC2 are each known to support long-term synaptic plasticity through distinct mechanisms (Costa-Mattioli and Monteggia, 2013; Huang et al, 2013). Therefore, we sought to investigate how the dual downregulation of mTORC1 and mTORC2 signaling affects cocaine-induced neuroadaptations, dopamine dynamics, basal synaptic plasticity, and neuronal morphology in the VTA. We sought to address the following questions. First, does mTOR deletion in adult mice alter neuronal morphology in the VTA? Previous studies have shown that hyperactive mTOR signaling is associated with hypertrophy of hippocampal and cortical neurons, including increases in soma surface area, number of dendritic spines, and enlargement of dendrites (Tavazoie et al, 2005; Chow et al, 2009; Luikart et al, 2011; Weston et al, 2012; Xiong et al, 2012), whereas downregulation of Akt, an upstream activator of mTORC1, and knockout of Rictor, a component of the mTORC2 complex, decrease the soma size of VTA dopamine neurons (Mazei-Robison et al, 2011). Second, does VTA-specific mTOR deletion alter dopamine release at dopaminergic axonal terminals in the NAc? Fast-scan cyclic voltammetry (FSCV) was used to detect dopamine release in response to single or burst electrical stimulation (Yorgason et al, 2011), and the impact of mTOR deletion on dopamine release was examined. Third, does VTA-specific mTOR deletion alter basal excitatory and inhibitory synaptic transmission? Finally, does mTOR deletion alter cocaine-induced CPP and neuroadaptations? By addressing these questions, our study provides evidence that VTA mTOR signaling regulates dopamine release in the NAc, basal inhibitory synaptic transmission in the VTA, cocaine-induced neuroadaptations in VTA dopamine neurons, and drug-cue associative learning.

Materials and methods

Animals

mTOR^wt/wt mice and homozygous mTOR-floxed mice (mTOR^loxP/loxP, Jax stock 011009), raised and maintained on C57BL/6J background, were obtained from the Jackson Laboratory (Bar Harbor, ME). All experiments were performed on adult male mice (8–10 weeks old at the beginning of the experiments).

Animal Surgery and Intra-VTA AAV Microinjections

Male adult mTOR^wt/wt and mTOR^loxP/loxP mice (8–10 weeks old) were anesthetized and placed in a Kopf stereotaxic device. AAV2.CMV.HI.eGFP-Cre.WPRE.SV40 (the Penn Vector Core of the University of Pennsylvania) was microinjected bilaterally into the VTA via a Nanoject III Programmable Nanoliter Injector (Drummond Scientific Company, Broomall, PA). Mice were allowed to recover for 2 weeks before experiments.

Immunofluorescence Staining

Mice were anesthetized and perfused transcardially with paraformaldehyde. Coronal VTA sections (30 μm) were cut and incubated with primary and secondary antibodies. Confocal imaging was performed using a Nikon TE2000-U inverted microscope equipped with the C1 Plus confocal system.

Microinjection of Alexa Fluor 594 into VTA Neurons

Alexa Fluor 594 dye (Thermo Fisher Scientific, Waltham, MA) (5 mM in 150 mM KCl) was injected into AAV2-Cre-GFP-positive neurons in fixed brain sections via iontophoretic injection (−2 nA for 3–5 min) (Dumitriu et al, 2011; Christian et al, 2017).

Brain Slice Preparation

The mouse brain was trimmed and embedded in 3% low-melting-point agarose, and horizontal midbrain slices or coronal striatal slices (200 μm thickness) were cut using Leica vibrating slicer VT1200s (Nussloch, Germany).

Fast-Scan Cyclic Voltammetry (FSCV) Recording of Dopamine Release

To measure dopamine release in the NAc shell with FSCV, a glass-encased cylindrical carbon fiber (7 μm diameter, Goodfellow, Oakdale, PA) microelectrode with an exposed final length of 100–150 μm was lowered into the NAc shell.

Western Blot Analysis

The western blot analysis of VTA or NAc tissue samples was performed with antibodies against p-S6 (Ser 235/236), S6, p-Akt (Ser 473), p-TH (Ser 40), tyrosine hydroxylase (TH), and dopamine transporter (DAT).

Slice Electrophysiology

Horizontal midbrain slices (200 μm thick) were cut using a vibrating slicer (Leica VT1200s). EPSCs and IPSCs were recorded as we have previously described (Pan et al, 2008). AMPA/NMDA receptor (AMPAR/NMDAR) ratio was measured based on published studies (Saal et al, 2003; Liu et al, 2005).

In Vivo Electrophysiology

Mice were anesthetized and positioned in a stereotaxic frame, and craniotomies were performed to allow in vivo single-unit recordings of VTA GABAergoc neurons. To confirm cell type and electrode placement, neurons were juxtacellularly labeled with neurobiotin.

Conditioned Place Preference

Cocaine CPP was based on published procedures (Vialou et al, 2012; Liu et al, 2016).

Statistics

Data are presented as mean±SEM. Synaptic currents were analyzed using Mini-analysis (Synaptosoft). CPP scores were calculated as the time spent in the cocaine-conditioned chamber minus that in the saline-conditioned chamber. Data sets were compared with either Student’s t-test or two-way ANOVA followed by Tukey’s post hoc analysis using Sigmaplot 11.2. For unpaired data that do not follow a normal distribution, the Mann–Whitney U-test was used, and data are reported as median (interquartile range). Results were considered to be significant at P<0.05.

Materials and methods are described in detail in the Supplementary Materials and Methods.

Results

AAV-Mediated Deletion of mTOR in the VTA

To delete mTOR in the VTA, we injected AAV2-Cre-GFP into the VTA bilaterally in mTOR-floxed mice (mTOR^loxP/loxP). AAV2-Cre-GFP was also bilaterally injected into the VTA of mTOR^wt/wt mice to serve as a control. The effectiveness of the AAV2-Cre-GFP was validated by our previous studies (Zhong et al, 2014). At 2 weeks after the AAV2-Cre-GFP injection, mice were killed and mTOR expression in the VTA was determined by immunofluorescence labeling using antibodies against mTOR and TH. GFP fluorescence was directly visualized, where it was observed predominantly in the nuclei of infected neurons. This nuclear localization is consistent with previous studies, and occurs because GFP is directly fused to Cre and a nuclear localization signal from SV40 (Kaspar et al, 2002; Zhong et al, 2014). Both TH⁺ dopamine neurons and TH⁻ non-dopamine neurons (putative GABAergic neurons) were infected by the AAVs. AAV2-Cre-GFP deleted mTOR in both dopamine neurons and non-dopamine neurons in the VTA in mTOR^loxP/loxP mice (n=4 mice; Figure 1a) but mTOR expression was abundant in mTOR^wt/wt mice (n=3 mice; Figure 1a). mTORC1 phosphorylates and activates its downstream effector S6 kinase, whereas the Ser-473 site of Akt is a substrate for mTORC2 phosphorylation (Laplante and Sabatini, 2012). Phospho-S6 (p-S6) expression in the VTA was significantly decreased in mTOR^loxP/loxP mice as shown by immunohistochemical staining (n=2 mice; Figure 1b) and western blot analysis compared with mTOR^wt/wt mice (17.7±2.9%, t₈=18.0, P<0.001, n=5 mice; Figure 1c and d). Similarly, phospho-Akt (p-Akt Ser-473) levels in the VTA were decreased in mTOR^loxP/loxP mice (15.4±4.1%, t₈=12.8, P<0.001, n=5 mice; Figure 1c and d). Thus, mTOR deletion decreased mTORC1 and mTORC2 signaling in the VTA.

Figure 1.

AAV2-Cre-GFP-mediated deletion of mTOR in the VTA. VTA immunostaining following mTOR deletion. (a) Immunofluorescence labeling indicates that mTOR expression remains in mTOR^wt/wt mice (n=3) but not mTOR^loxP/loxP mice (n=4) 2–3 weeks after intra-VTA injection of AAV2-Cre-GFP. Scale bar, 50 μm. Arrows: representative dopamine neurons; arrowheads, representative non-dopamine neurons. (b) Immunofluorescence labeling indicates that mTOR deletion decreased phosphorylated S6 kinase (p-S6 S235/236) expression in the VTA (n=2 mice). (c, d) Western blots (c) and normalized data (d) revealed that mTOR deletion led to decreases in p-S6 S235/236 (mTORC1-dependent) and p-Akt S473 (mTORC2-dependent) in the VTA (n=5 mice/group; ***P<0.001, ns, not significant).

mTOR Deletion Did Not Alter the Morphology of VTA Neurons

Genetic mutations that lead to hyperactive mTORC1 signaling cause neuronal hypertrophy in the hippocampus and cortex, as shown by increases in the size of somata and dendrites, and the number of dendritic spines (Tavazoie et al, 2005; Luikart et al, 2011; Weston et al, 2012; Xiong et al, 2012). It was of interest to investigate whether mTOR deletion alters the morphology of VTA neurons. We injected Alexa Fluor 594 (5 mM) into GFP-positive neurons in the VTA in fixed brain sections from mTOR^loxP/loxP and mTOR^wt/wt mice that received intra-VTA injection of AAV2-Cre-GFP 2 weeks prior (Supplementary Figure S1). We found that the surface area of somata, dendritic length, dendritic thickness, and number of dendrites per neuron in VTA neurons were not significantly different between mTOR^wt/wt and mTOR^loxP/loxP mice (n=13–17 cells/4–5 mice; P>0.05; Supplementary Figure S1). For technical reasons, we did not identify whether the dye-injected neurons were dopamine neurons or non-dopamine neurons. Prior TH immunostaining of VTA sections significantly retarded subsequent Alexa 594 diffusion into dendrites of injected neurons, whereas post hoc TH immunostaining after Alexa 594 injection caused significant loss of the Alexa 594 at dendrites, in particular, distal dendrites. Permeabilization of the cell membrane required for TH antibody incubation may be responsible for the dye loss at distal dendrites. Thus, mTOR deletion in the VTA did not result in apparent changes in neuronal morphology.

VTA-Specific mTOR Deletion Decreased Dopamine Release and Reuptake in the NAc Shell

Dopamine is synthesized by dopamine neurons in the VTA and is axonally transported for release in the NAc. Using FSCV to detect evoked dopamine release in striatal slices from mTOR^wt/wt and mTOR^loxP/loxP mice, we investigated whether mTOR deletion in the VTA altered dopamine release in the NAc shell. We chose to record from the NAc shell for the following reasons. Both microdialysis and in vivo FSCV have shown that natural rewards (palatable food, sucrose) increase dopamine release in the shell but not the core, whereas aversive tastes decrease dopamine release in the shell (reviewed by Saddoris et al, 2013). In addition, cocaine administration causes a greater increase in dopamine transients in the shell compared with the core (Aragona et al, 2008). FSCV recordings were made blindly to mouse genotype, and dopamine release was detected by a carbon-fiber microelectrode placed in the NAc shell (Yorgason et al, 2011). Dopamine release was evoked by a single electrical stimulus pulse or a train of stimuli (5 pulses) at 10, 30, or 50 Hz at a fixed intensity (250 μA, 0.1 ms duration). The average peak concentration of dopamine in the NAc shell was decreased in mTOR^loxP/loP mice at single-pulse and 10, 30, and 50 Hz 5-pulse stimulation (1 pulse: t₁₅=3.6, P=0.003; 10 Hz: t₁₅=4.9, P<0.001; 30 Hz: t₁₅=9.0, P<0.001; 50 Hz: t₁₅=11.0, P<0.001; n=3–4 mice; Figure 2a and b). Thus, mTOR deletion in the VTA decreased dopamine release in its target region, the NAc shell.

Figure 2.

VTA-specific mTOR deletion significantly decreased dopamine release and reuptake in the NAc shell. (a) Concentration trace (top) and color plot (bottom) for dopamine release triggered by electrical stimulation of the NAc shell in mTOR^wt/wt and mTOR^loxP/loxP mice at 2 weeks after intra-VTA injection of AAV2-Cre-GFP. Top, representative traces showing the concentration of dopamine (μM) over time in response to 5-pulse electrical stimulation at 30 Hz. Inset shows characteristic dopamine voltammogram. Bottom, corresponding color plot depicting the voltammetric data with time on the x axis, applied scan potential (Eapp) on the y axis, and background-subtracted faradaic current shown on the z axis in pseudocolor. Dopamine can be identified by an oxidation peak (green) at +0.6 V and a smaller reduction peak (black) at −0.2 V. (b) Summarized data showing the average peak concentration of dopamine in the NAc shell in response to single-pulse and 5-pulse stimulation (10, 30, and 50 Hz). Dopamine release was significantly decreased in mTOR^loxP/loxP mice at single-pulse, and 10, 30, and 50 Hz stimulations (**P<0.01, ***P<0.001, n=8–9) compared with mTOR^wt/wt mice. (c) Summarized data showing that decay time constants (τ) of dopamine transients were significantly prolonged in mTOR^loxP/loxP mice at single-pulse and 10, 30, and 50 Hz stimulations (*P<0.05, ***P<0.001, n=8–9 from 3–4 mice) compared with mTOR^wt/wt mice. A full color version of this figure is available at the Neuropsychopharmacology journal online.

Additionally, VTA mTOR deletion prolonged the decay of dopamine responses in the NAc shell (Figure 2a and c). Dopamine reuptake by DAT is the primary mechanism responsible for extracellular dopamine clearance in the brain (Giros et al, 1996). The decay time constant (τ) of the falling phase of dopamine transients is a function of the dopamine uptake rate (Yorgason et al, 2011). We found that the decay time constant τ of the dopamine responses in mTOR^loxP/loxP mice was significantly prolonged compared with that of mTOR^wt/wt mice at all stimulation frequencies (1 pulse: t₁₅=2.3, P=0.037; 10 Hz: t₁₅=5.7, P<0.001; 30 Hz: t₁₅=4.2, P<0.001; 50 Hz: t₁₅=2.5, P=0.024; Figure 2c). These results suggest that loss of mTOR impaired dopamine clearance in the NAc shell.

What might be the mechanisms for mTOR deletion-induced decreases in dopamine release and reuptake? TH is the rate-limiting enzyme for dopamine synthesis (Dunkley et al, 2004). TH phosphorylation at Ser40 increases the catalytic activity of TH and thereby dopamine synthesis (Dunkley et al, 2004). We examined whether mTOR deletion altered protein levels of phosphorylated TH at Ser40 (p-TH S40) and total TH in VTA tissue samples using western blot analysis. There was a significant decrease in the protein level of p-TH S40 in mTOR^loxP/loxP mice (58.2±9.8%, n=6 mice) compared with that of mTOR^wt/wt mice (t₁₀=2.8, P=0.018), whereas total TH remained unchanged (t₁₀=0.6, P=0.591). The p-TH S40/total TH ratio was decreased in mTOR^loxP/loxP mice (56.0±6.8%, t₁₀=3.5, P=0.006; Figure 3a and c). The decrease in p-TH S40 in mTOR^loxP/loxP mice suggests a decrease in dopamine synthesis that may explain why dopamine responses are decreased in mTOR^loxP/loxP mice.

Figure 3.

VTA-specific mTOR deletion decreased p-TH S40 protein expression in the VTA and decreased DAT protein expression in the NAc. (a) Representative western blots for p-TH (S40), total TH, and β-actin in VTA homogenates prepared from mTOR^wt/wt and mTOR^loxP/loxP mice after intra-VTA injection of AAV2-Cre-GFP. (b) Representative western blots for DAT and β-actin in NAc homogenates prepared from mTOR^wt/wt and mTOR^loxP/loxP mice after intra-VTA injection of AAV2-Cre-GFP. (c) Summarized data indicate that the protein expression of p-TH (S40) was significantly decreased in the VTA of mTOR^loxP/loxP mice compared with mTOR^wt/wt mice (*P<0.05). Total TH protein expression was not significantly altered (P>0.05). Therefore, the p-TH/TH ratio was significantly decreased in the VTA in mTOR^loxP/loxP mice (**P<0.01). VTA-specific deletion of mTOR significantly decreased DAT protein expression in the NAc compared with mTOR^wt/wt mice (**P<0.01, n=6 mice for each comparison). Immunoreactivity was normalized to β-actin and is presented as a percentage of that of mTOR^wt/wt mice.

DAT is expressed on the plasma membrane of axons from dopaminergic neurons in both the NAc shell and core (Nirenberg et al, 1997). We also examined whether mTOR deletion in the VTA altered DAT protein levels in the NAc. Western blot analysis indicated that DAT protein levels were significantly decreased in mTOR^loxP/loxP mice (41.3±11.3%, n=6 mice) compared with those of mTOR^wt/wt mice (t₁₀=4.0, P=0.002; Figure 3b and c). The decrease in DAT likely explains why the decay time constant of dopamine release in the NAc was prolonged in mTOR^loxP/loxP mice.

Effects of VTA-Specific mTOR Deletion on Excitatory and Inhibitory Synaptic Transmission in VTA Dopamine Neurons

We examined whether mTOR deletion altered basal excitatory and inhibitory synaptic transmission in VTA dopamine neurons. mTOR^wt/wt and mTOR^loxP/loxP mice received intra-VTA injections of AAV2-Cre-GFP. At 2 weeks following the injection, mice were killed and midbrain slices were prepared. The identification of dopamine neurons and recordings of miniature excitatory postsynaptic currents (mEPSCs) and spontaneous EPSCs (sEPSCs) are detailed in the Supplementary Methods. There was no significant change in the mean frequency (t₂₃=0.01, P=0.992) or amplitude (t₂₃=1.4, P=0.176) of mEPSCs in VTA dopamine neurons between mTOR^wt/wt and mTOR^loxP/loxP slices (Supplementary Figure S2). The mean frequency (t₂₄=0.7, P=0.493) and amplitude (t₂₃=0.9, P=0.365) of sEPSCs were not significantly different between mTOR^wt/wt and mTOR^loxP/loxP slices (Supplementary Figure S2). Together, these results indicate that genetic deletion of mTOR did not alter basal excitatory synaptic transmission in VTA dopamine neurons.

We also examined whether mTOR deletion altered basal inhibitory synaptic transmission in VTA dopamine neurons. We found that mTOR deletion had no significant effects on the mean frequency (t₂₈=0.8, P=0.443) and mean amplitude (t₂₈=0.7, P=0.463) of mIPSCs (Supplementary Figure S3). In contrast, mTOR deletion significantly increased the frequency (t₂₅=2.4, P=0.026) but not the amplitude (t₂₅=0.7, P=0.477) of sIPSCs (Supplementary Figure S3). Thus, mTOR deletion enhances basal inhibitory synaptic transmission by increasing the frequency of sIPSCs in VTA dopamine neurons.

mTOR Deletion Increased In Vivo AP Firing of VTA GABAergic Neurons

VTA dopamine neurons receive GABAergic inhibitory synaptic inputs from local interneurons as well as from medium spiny neurons (MSNs) in the NAc (Bocklisch et al, 2013). The increase in sIPSC frequency in mTOR^loxP/loxP mice might be attributable to an increase in AP firing in GABAergic VTA neurons. To test this possibility, we made single-unit recordings of AP firing in vivo in mTOR^wt/wt and mTOR^loxP/loxP mice that received intra-VTA injection of AAV2-Cre-GFP 2 weeks before the recordings. Mice were anesthetized with urethane and in vivo single-unit recordings were performed. VTA GABA neurons were identified by short-duration (<1 ms), nonbursting, high-frequency (>10 Hz) spikes (Steffensen et al, 1998) (Figure 4a). These firing characteristics could be distinguished from those of VTA dopamine neurons that exhibit a broad triphasic extracellular action potential with a width >2 ms and a relatively slow firing rate (<10 Hz) (Ungless et al, 2004). Furthermore, a subset of VTA GABAergic neurons were validated by juxtacellular labeling with neurobiotin and post hoc TH immunostaining to verify that neurobiotin-labeled neurons were TH negative (Ungless et al, 2004; Chaudhury et al, 2013) (Figure 4b). We found that the frequency of AP firing of GABAergic neurons was significantly increased in mTOR^loxP/loxP mice compared with that of mTOR^wt/wt mice (t₂₇=2.2, P=0.035; Figure 4a).

Figure 4.

VTA-specific mTOR deletion increased in vivo AP firing of VTA GABAergic neurons. (a) mTOR deletion in the VTA led to an increase in the frequency of action potential firing by VTA GABAergic neurons (*P=0.035, n=14–15 cells from 5–6 mice). GABAergic neurons were identified by short-duration (<1 ms), nonbursting, high-frequency (>10 Hz) spikes. (b) Neurobioton labeling of recorded VTA neuron and post hoc immunostaining for TH and GFP allows identification of Cre-expressing GABAergic neurons from in vivo single-unit recordings. (c) mTOR deletion in the VTA decreased peak voltage-gated K⁺ currents at voltage steps to −30 mV or greater (*P<0.05, **P<0.01, ***P<0.001, n=11–12 from 3–4 mice).

We also recorded AP firing in cell-attached mode in GABA neurons in VTA slices, identified by the criteria described in the Supplementary Materials and Methods. The AP frequency was significantly increased in VTA GABA neurons in slices from mTOR^loxP/loxP mice (median frequency: 4.4 Hz (3.6–5.2 Hz), n=11) compared with that of mTOR^wt/wt mice (median frequency: 2.4 Hz (2.1–4.2 Hz), n=12; Mann–Whitney U=30.0, P=0.029). What might be the mechanisms for the increase in AP firing of VTA GABAergic neurons? Voltage-gated K⁺ channels control the repolarization of APs, and partial blockade of K⁺ channels significantly increases AP firing in GABAergic interneurons (Ding et al, 2011). We therefore examined whether voltage-gated K⁺ currents were altered following mTOR deletion. Whole-cell voltage clamp recordings were made from VTA GABAergic neurons (Figure 4c), and voltage-gated K⁺ currents were induced by depolarization steps (from −60 mV to +10 mV, 10 mV increments, 1 s duration). We found that mTOR deletion significantly decreased the peak amplitude of K⁺ currents at voltage steps to −30 mV or greater (Figure 4c). Thus, this mTOR deletion-induced decrease in voltage-gated K⁺ currents may contribute to the increase in AP firing in VTA GABAergic neurons, and the enhancement of GABAergic inhibition to VTA dopamine neurons.

VTA-Specific Deletion of mTOR Attenuated Cocaine-Induced CPP

We examined whether deletion of mTOR in the VTA altered cocaine-induced CPP. mTOR^loxP/loxP and mTOR^wt/wt mice that received intra-VTA AAV2-Cre-GFP injections 2 weeks prior underwent saline and cocaine conditioning. Mice that exhibited unconditioned place preference (⩾180 s) during the pretest were excluded from further experiments (n=3). The remaining mice did not exhibit baseline bias (P>0.05; Figure 5a). Then, cocaine (15 mg/kg, i.p.) or saline place conditioning was conducted twice daily for 2 days (see Materials and Methods). At 24 h after the last pairing, CPP was tested without any drug or vehicle administration. Two-way ANOVA revealed that genotype (F_{(1, 38)}=4.8, P=0.035) and cocaine conditioning (F_{(1, 38)}=31.1, P<0.001) had significant effects on the preference score, and there was a significant interaction between genotype and cocaine conditioning (F_{(1, 38)}=6.9, P=0.012; Figure 5b). Tukey’s post hoc tests showed that cocaine conditioning led to a significant increase in the preference score (317±30 s) in mTOR^wt/wt mice (P<0.001), and that this increase was significantly attenuated in mTOR^loxP/loxP mice (156±37 s; P<0.001; Figure 5b). Thus, mTOR deletion from the VTA attenuates cocaine-cue associative learning.

Figure 5.

Genetic deletion of mTOR in the VTA attenuated cocaine CPP. (a) mTOR^wt/wt and mTOR^loxP/loxP mice that received intra-VTA injection of AAV2-Cre-GFP exhibited no unconditioned place preference during the pretest (P>0.05, n=8–12 mice). (b) Cocaine CPP was attenuated in mTOR^loxP/loxP mice compared with that of mTOR^wt/wt mice (***P<0.001, mTOR^wt/wt-saline, n=9 mice; mTOR^wt/wt-cocaine, n=10 mice; mTOR^loxP/loxP-saline, n=8 mice; mTOR^loxP/loxP-cocaine, n=12 mice). (c) Compared with saline conditioning, cocaine significantly increased locomotor activity over the 2 days of place conditioning (***P<0.001; n=8–12), and locomotor activity was not significantly different among different genotypes (P=0.741; n=8–12 mice).

During place conditioning, locomotor activity in the conditioning chambers was tracked by infrared photobeam breaks. We compared locomotor activity in saline- or cocaine-conditioned mTOR^wt/wt and mTOR^loxP/loxP mice over the course of cocaine and saline conditioning sessions. Locomotor activity was analyzed with a mixed ANOVA that included between-subject factors of place conditioning and genotype and the within-subject factor of conditioning sessions. Cocaine conditioning significantly increased locomotor activity over the 2 days of place conditioning (F_{(1, 77)}=51.2, P<0.001), locomotor activity was not significantly different among the different genotypes (F_{(1, 77)}=0.1, P=0.944), and there was no significant interaction between place conditioning and genotypes (F_{(1, 77)}=0.3, P=0.612, Figure 5c). Thus, cocaine-induced increases in locomotor activity were not significantly different between mTOR^wt/wt and mTOR^loxP/loxP mice. These results suggest that the reduction of CPP scores in mTOR^loxP/loxP mice could not be attributed to the secondary consequence of changes in locomotor activity.

mTOR Deletion Blocked Cocaine-Induced Potentiation of Excitatory Synaptic Transmission on VTA Dopamine Neurons

Single or repeated i.p. cocaine injections lead to an increase in AMPAR/NMDAR ratio in VTA dopamine neurons (Ungless et al, 2001; Borgland et al, 2004; Liu et al, 2005; Mameli et al, 2009; Liu et al, 2016). We examined whether cocaine CPP was associated with changes in the AMPAR/NMDAR ratio in VTA dopamine neurons, and if so, whether these effects were altered by mTOR deletion. At 1 day after the CPP test, the mice shown in Figure 5 were killed and midbrain slices were prepared. The AMPAR/NMDAR ratio was measured in VTA dopamine neurons in slices prepared from these four groups of mice. Two-way ANOVA showed that mTOR deletion (F_{(1, 31)}=13.1, P=0.001) and cocaine conditioning (F_{(1, 31)}=9.5, P=0.005) had significant effects on the AMPAR/NMDAR ratio, and there was a significant interaction between mTOR deletion and place conditioning (F_{(1, 31)}=10.0, P=0.004; Figure 6a and b). Tukey’s post hoc tests showed that cocaine conditioning significantly increased the AMPAR/NMDAR ratio (P<0.001) in mTOR^wt/wt mice compared with that of saline conditioning, whereas the increase was absent in mTOR^loxP/loxP mice (P<0.001). These results indicate that mTOR deletion blocked the cocaine conditioning-induced increase in the AMPAR/NMDAR ratio in VTA dopamine neurons.

Figure 6.

Genetic deletion of mTOR in the VTA blocked the increase in AMPAR/NMDAR ratio induced by a single cocaine injection in vivo. (a) Representative AMPAR- and NMDAR-mediated evoked EPSCs recorded from VTA dopamine neurons in saline- or cocaine-conditioned mTOR^wt/wt and mTOR^loxP/loxP mice 2 weeks after intra-VTA injection of AAV2-Cre-GFP. (b) Cocaine conditioning significantly increased the AMPAR/NMDAR ratio in mTOR^wt/wt slices (***P<0.001, n=7–8), whereas this increase was absent in mTOR^loxP/loxP slices (***P<0.001, n=8–9). (c) Representative mEPSCs recorded from VTA dopamine neurons in saline- or cocaine-conditioned mTOR^wt/wt and mTOR^loxP/loxP mice. (d, e) Cocaine place conditioning significantly increased the frequency and amplitude (***P<0.001, n=13–15) of mEPSCs in mTOR^wt/wt slices, whereas these increases were blocked in mTOR^loxP/loxP slices (**P=0.002, ***P<0.001, n=14–15). Each data set was obtained from 3–4 mice.

We then examined whether mEPSCs in the VTA were altered by cocaine conditioning and mTOR deletion. Two-way ANOVA showed that mTOR deletion and cocaine conditioning had significant effects on the frequency (mTOR deletion, F_{(1, 53)}=6.5, P=0.014; cocaine conditioning, F_{(1, 53)}=8.4, P=0.005) and amplitude (mTOR deletion, F_{(1, 53)}=14.9, P<0.001; cocaine conditioning, F_{(1, 53)}=7.7, P=0.008) of mEPSCs, and there were significant interactions between mTOR deletion and cocaine conditioning on the frequency (F_{(1, 53)}=4.1, P=0.048; Figure 6c and d) and amplitude (F_{(1, 53)}=4.3, P=0.004; Figure 6c and e) of mEPSCs. Tukey’s post hoc tests showed that cocaine conditioning significantly increased the frequency and amplitude of mEPSCs in mTOR^wt/wt mice compared with saline conditioning (P<0.001), whereas the increases were absent in mTOR^loxP/loxP mice (frequency, P=0.002; amplitude, P<0.001). Thus, although mTOR deletion did not alter basal mEPSCs, it blocked cocaine conditioning-induced increases in the frequency and amplitude of mEPSCs in VTA dopamine neurons.

VTA-Specific mTOR Deletion Attenuated Cocaine CPP-Induced Reduction of GABAergic Inhibition

Cocaine exposure in vivo leads to a decrease in the frequency and amplitude of IPSCs in VTA dopamine neurons (Liu et al, 2005; Bocklisch et al, 2013). We examined whether cocaine conditioning and mTOR deletion altered sIPSCs in VTA dopamine neurons ex vivo. At 1 day after the CPP test, the mice were killed and midbrain slices were prepared. sIPSC in VTA dopamine neurons were measured in slices prepared from saline- or cocaine-conditioned mTOR^wt/wt or mTOR^loxP/loxP mice. We found that mTOR deletion and cocaine conditioning had significant effects on the mean frequency of sIPSCs (mTOR deletion: F_{(1, 50)}=31.9, P<0.001; cocaine conditioning: F_{(1, 50)}=36.5, P<0.001; mTOR deletion × cocaine conditioning interaction: F_{(1, 50)}=4.2, P=0.045; Figure 7a and b) and mean amplitude of sIPSCs (mTOR deletion: F_(1,50)=8.4, P=0.006; cocaine conditioning: F_{(1, 50)}=5.9, P=0.019; mTOR deletion × cocaine conditioning interaction: F_{(1, 50)}=5.1, P=0.029; Figure 5a and c). Tukey’s post hoc tests indicated that cocaine conditioning significantly decreased the frequency (P=0.008; Figure 7b) and the mean amplitude (P=0.002; Figure 7c) of sIPSCs in mTOR^wt/wt mice. However, mTOR deletion blocked the cocaine conditioning-induced decrease in the amplitude (P<0.001; Figure 7c) of sIPSCs. Although cocaine conditioning did decrease sIPSC frequency in mTOR knockout mice, sIPSC frequency was significantly greater in mTOR knockout mice compared with mTOR^wt/wt mice following cocaine conditioning (P=0.014; Figure 7b). Together, these results indicate that cocaine CPP led to a decrease in GABAergic inhibition to VTA dopamine neurons in mTOR^wt/wt mice, and this decrease was attenuated in mTOR^loxP/loxP mice.

Figure 7.

Genetic deletion of mTOR in the VTA attenuated the reduction of GABAergic inhibition to dopamine neurons induced by cocaine CPP. (a) Representative sIPSCs recorded from VTA dopamine neurons in slices prepared from saline- or cocaine-conditioned mTOR^wt/wt and mTOR^loxP/loxP mice after intra-VTA injection of AAV2-Cre-GFP. (b) Mean sIPSC frequency in mTOR^loxP/loxP mice is significantly increased compared with mTOR^wt/wt mice with saline conditioning (***P<0.001, n=12–13). Mean sIPSC frequency was significantly decreased in cocaine-conditioned mTOR^wt/wt mice compared with that of saline-conditioned mice (**P=0.008, n=13–14), and this decrease was blocked by mTOR deletion (*P=0.014, n=12–13). (c) Mean sIPSC amplitude was significantly decreased in cocaine-conditioned mTOR^wt/wt mice (**P=0.002, n=12–13), and this decrease was blocked in mTOR^loxP/loxP mice (***P<0.001, n=13–14). Each data set was obtained from 3–4 mice.

Discussion

In the present study, we used AAV2-Cre-GFP to delete mTOR in adult mTOR^loxP/loxP mice, thus allowing us to specifically investigate the dual role of mTORC1 and mTORC2 signaling in adult neurons by avoiding potential effects of mTOR deletion on neuronal development. We first examined the impact of loss of mTOR on neuronal morphology, dopamine dynamics, and basal synaptic plasticity in the VTA, and then examined whether mTOR deletion altered cocaine-induced CPP and neuroadaptations. We showed that VTA mTOR signaling regulates dopamine dynamics, basal inhibitory synaptic transmission, and cocaine-induced neuroadaptations and reward.

mTOR Deletion Did Not Significantly Alter the Soma Size of VTA Neurons

Hyperactive mTOR signaling leads to increases in the soma surface area and number of dendritic spines (Tavazoie et al, 2005; Luikart et al, 2011; Weston et al, 2012; Xiong et al, 2012). AAV-Cre-mediated deletion of Rictor, a critical component of mTORC2, causes an ~20% decrease in the surface area of dopamine neuron somata (Mazei-Robison et al, 2011). We found that mTOR deletion did not significantly affect the soma size, nor the dendritic morphology of VTA neurons, as shown by Alexa 594 dye injection. However, we must acknowledge that only a relatively small numbers of neurons were sampled in the present study, and some dendritic branches were severed during tissue sectioning, and thus the current approach may not be sensitive enough to detect subtle differences of neuronal morphology induced by mTOR deletion.

mTOR Deletion Decreased Dopamine Release and Reuptake

The mTORC1 inhibitor rapamycin induces the formation of autophagic vacuoles in dopaminergic axons, leading to decreases in axonal profile volumes, synaptic vesicle numbers, and evoked dopamine release (Hernandez et al, 2012), whereas a decrease in mTORC2 signaling in the VTA was shown to decrease dopamine release in the NAc (Mazei-Robison et al, 2011). Consistent with these findings, VTA-specific mTOR deletion led to a decrease in the mean peak amplitude of evoked dopamine transients in the NAc shell either by single or burst stimulation at high frequencies. Western blot analysis indicated that protein levels of phosphorylated TH at Ser40 were decreased with mTOR deletion in the VTA, despite unaltered total TH. As phosphorylation at Ser40 increases the catalytic activity of TH (Dunkley et al, 2004)—the rate-limiting enzyme for dopamine synthesis—this large decrease in p-TH S40 may significantly decrease dopamine synthesis and contribute to the decreased amplitude of evoked dopamine transients. Additionally, rapamycin treatment causes a decrease in the mTORC1-dependent maintenance of dopamine synaptic vesicles (Hernandez et al, 2012). Thus, reductions in mTOR signaling, either through deletion or inhibition, may result in a decrease in releasable vesicular dopamine through parallel deficits in dopamine synthesis and vesicular maintenance.

The DAT-mediated reuptake of dopamine is one of the key factors that shape the decay kinetics of dopamine transients (Giros et al, 1996). We found that the decay time constants of evoked dopamine transients, which are a reliable measure for assessing dopamine uptake (Yorgason et al, 2011), were significantly prolonged in VTA mTOR-deleted mice compared with that of wild-type mice at all stimulation frequencies. Consistent with this, we found that protein levels of DAT in the NAc were substantially decreased following mTOR deletion in the VTA. As DAT is the primary mechanism for extracellular dopamine clearance in the brain (Giros et al, 1996), the retardation of dopamine clearance is likely attributable to the observed decrease in DAT expression. Interestingly, the selective mTORC1 inhibitor rapamycin did not significantly alter the decay of evoked dopamine transients in striatal slices (Hernandez et al, 2012). One possibility is that loss of mTORC2 but not mTORC1 may be responsible for the retardation of dopamine clearance.

Effects of mTOR Deletion on Basal Synaptic Transmission in the VTA

Several studies indicate mTOR hyperactivation causes an increase in basal excitatory transmission in most cases but a decrease in basal inhibitory transmission in the hippocampus (Tavazoie et al, 2005; Luikart et al, 2011; Weston et al, 2012; Xiong et al, 2012; Bateup et al, 2013). Here we found that the mean frequency and amplitude of mEPSCs and sEPSCs in VTA dopamine neurons were not significantly different between wild-type mice and mTOR^loxP/loxP mice, suggesting that mTOR deletion in the VTA had no significant effects on basal excitatory transmission. In contrast, mTOR deletion in the VTA led to an increase in the mean frequency of sIPSCs without significantly altering mIPSCs or sIPSC amplitude. mIPSCs are produced by the quantal release of GABA from single vesicles, whereas sIPSCs are largely action potential driven. These results suggest that mTOR deletion leads to an increase in GABAergic neuron firing but has no significant effect on the quantal release of GABA nor the expression and/or function of GABA_A receptors. Consistent with this idea, we found that mTOR deletion caused a significant increase in AP firing in VTA GABAergic neurons in vivo and in vitro, and that voltage-gated K⁺ currents were significantly decreased in VTA GABAergic neurons following mTOR deletion. K⁺ channels control the repolarization of APs, and blockers that produce partial blockade of K⁺ channels significantly increase AP firing in GABAergic interneurons (Ding et al, 2011). The mTOR deletion-induced decrease in voltage-gated K⁺ currents may contribute to the increase in AP firing in VTA GABAergic neurons. Overall, mTOR deletion leads to an increase in inhibitory synaptic input in VTA dopamine neurons, likely through an enhancement of VTA GABAergic neuronal firing.

Effects of mTOR Deletion on Cocaine-Induced CPP and Synaptic Alterations

Several previous studies have demonstrated roles for mTOR signaling in regulating drug- or alcohol-associated behaviors. Trefoil factor 3 (TFF3), a brain-synthesized peptide thought to activate mTOR signaling, can enhance cocaine-induced mTOR activation, hyperlocomotion, and CPP (Luo et al, 2016). Inhibition of GSK-3, an mTORC1 inhibitor, disrupts the reconsolidation of cocaine-associated reward memories (Shi et al, 2014). Systemic or intra-NAc injection of rapamycin has been shown to attenuate many behavioral effects of drug and alcohol abuse (Dayas et al, 2012; Neasta et al, 2014; Beckley et al, 2016), including for cocaine (Wang et al, 2010; Wu et al, 2011; Bailey et al, 2012; James et al, 2014, 2016). Systemic injections of rapamycin before CPP testing, but not during the conditioning phase, attenuated CPP in mice, suggesting that rapamycin blocked the expression, but not the acquisition of cocaine CPP (Bailey et al, 2012).

Modulation of dopamine, glutamate, and GABA synaptic transmission might contribute to the mTOR deletion-induced disruption of cocaine CPP. First, VTA mTOR deletion caused a reduction of stimulus-evoked dopamine release in one of its primary target regions, the NAc shell. This reduced dopamine release may be the result of reduced phosphorylation of TH. mTOR deletion also increased the decay time constant of dopamine responses, likely because of decreased dopamine uptake resulting from a reduction in DAT expression. This decreased dopamine synthesis and availability of binding sites for cocaine might dampen the cocaine-induced elevation of dopamine levels in the NAc. Second, although VTA mTOR deletion had no effects on basal excitatory synaptic transmission, it blocked cocaine-induced increases in mEPSCs and AMPAR/NMDAR ratio. It has been shown that GluA1 knockout prevents cocaine-induced increases in the AMPAR/NMDAR ratio in VTA dopamine neurons and cocaine CPP (Dong et al, 2004). Cocaine exposure activates mTORC1 signaling in the VTA and NAc, and rapamycin blocks the cocaine-induced increase in GluA1 levels in the NAc (Wu et al, 2011; James et al, 2014). These data appear to support a model in which cocaine exposure activates mTORC1 signaling, leading to insertion of synaptic GluA1, potentiation of excitatory transmission in the VTA, and formation of cocaine-cue associative memories.

Finally, VTA mTOR deletion led to an enhancement of sIPSCs in VTA dopamine neurons that can be attributed to an increase in AP firing in VTA GABA neurons. It has been shown that reduced mTORC2 signaling can cause downregulation of K⁺ channel subunits in the VTA (Mazei-Robison et al, 2011). We suspect that the mTOR deletion-induced reduction of mTOC2 signaling leads to a decrease in voltage-gated K⁺ currents in VTA GABA neurons and an increase in AP firing. In addition, mTOR deletion blocked the cocaine-induced reduction of sIPSC amplitude in VTA dopamine neurons. Although cocaine reduced sIPSC frequency in VTA dopamine neurons from mTOR-deleted mice, sIPSC frequency did not differ between saline-treated wild-type mice and cocaine-treated, mTOR-deleted mice. Thus, mTOR signaling is necessary for the cocaine-induced potentiation of glutamatergic excitation, and may also contribute to the reduction of GABAergic inhibition in VTA dopamine neurons. However, as both mTORC1 and mTORC2 signaling are disrupted following mTOR deletion, future work is necessary to parse out the roles of mTORC1 and mTORC2 in regulating dopamine dynamics and cocaine-induced synaptic plasticity and behavior.

Funding and disclosure

This work was supported by the NIH Grants DA035217 and MH101146 to Q-SL, and by F30MH115536 to CRV. It was also partially funded through the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin. CRV is a member of the Medical Scientist Training Program at the Medical College of Wisconsin that is supported by training grant NIGMS T32-GM080202. The authors declare no conflict of interest.